Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice

Neuroscience

Volumn 252, Issue , 2013, Pages 13-23

  Jellen, L C ^a   Lu, L ^b,c   Wang, X ^b   Unger, E L ^a   Earley, C J ^d   Allen, R P ^d   Williams, R W ^b   Jones, B C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c NANTONG UNIVERSITY   (China)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BXD; Cxcl12; Drd2; Hbb b1; Recombinant inbred strains

Indexed keywords

HEMOGLOBIN BETA CHAIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; CONTROLLED STUDY; CXCL12 GENE; DOPAMINERGIC SYSTEM; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HBB B1 GENE; HORMONE ACTION; IRON DEFICIENCY; MALE; MESENCEPHALON; MICROARRAY ANALYSIS; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SDF 1 GENE; SUBSTANTIA NIGRA; TFRC GENE; UPREGULATION;

ALAS2; AMINOLEVULINIC ACID SYNTHASE 2; ANALYSIS OF COVARIANCE; ANCOVA; BXD; CXCL12; DOPAMINE RECEPTOR 2; DRD2; FALSE DISCOVERY RATE; FDR; FERRITIN HEAVY-CHAIN; FHC; GENE SET ENRICHMENT ANALYSIS; GSEA; HBB-B1; ID; IRON DEFICIENCY; LOG(2) RATIO; LR RATIO; RADICAL S-ADENOSYL METHIONINE DOMAIN CONTAINING 2; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT INBRED STRAINS; RESTLESS LEGS SYNDROME; RLS; RSAD2; RT-PCR; TFRC; TH; TRANSFERRIN RECEPTOR; TYROSINE HYDROXYLASE; VENTRAL MIDBRAIN; VMB;

ANIMALS; CHEMOKINE CXCL12; DOPAMINE; HEMOGLOBINS; IRON; MESENCEPHALON; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RESTLESS LEGS SYNDROME; TRANSCRIPTOME;

EID: 84883286550     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.058     Document Type: Article

References (50)

1. Allen R.P., Auerbach S., Bahrain H., Auerbach M., Earley C.J. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol 2013, 88:261-264.
2. Astrakas L.G., Konitsiotis S., Margariti P., Tsouli S., Tzarouhi L., Argyropoulou M.I. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology 2008, 71:911-916.
3. Beard J.L., Chen Q., Connor J., Jones B.C. Altered monoamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 1994, 48:621-624.
4. Beard J.L., Erikson K.M., Jones B.C. Neurobehavioral analysis of developmental iron deficiency in rats. Behav Brain Res 2002, 134:517-524.
5. Beard J.L. Iron deficiency alters brain development and functioning. J Nutr 2003, 133:1468S-1472S.
6. Beard J.L., Wiesinger J.A., Connor J.R. Pre- and Post-weaning iron deficiency alters myelination in Sprague-Dawley rats. Dev Neurosci 2003, 25:308-315.
7. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
8. Biagioli M., Pinto M., Cesselli D., Zaninello M., Lazarevic D., Roncaglia P., Simone R., et al. Unexpected expression of alpha- and beta globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci 2009, 106:15454-15459.
9. Bianco L.E., Wiesinger J., Earley C.J., Jones B.C., Beard J.L. Iron deficiency alters dopamine uptake and response to l-DOPA injection in Sprague-Dawley rats. J Neurochem 2008, 106:205-215.
10. Brunette K.E., Tran P.V., Wobken J.D., Carlson E.S., Georgieff M.K. Gestational and neonatal iron deficiency alters apical dendrite structure of CA1 Pyramidal neurons in adult rat hippocampus. Dev Neurosci 2010, 32:238-248.
11. Burhans M.S., Dailey C., Beard Z., Wiesinger J., Murray-Kolb L., Jones B.C., Beard J.L. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci 2005, 8:31-38.
12. Boone E.M., Cook M.N., Hou X., Jones B.C. Sex and strain influence the effects of ethanol on central monoamines. J Stud Alcohol 1997, 58:590-599.
13. Carlson E.S., Stead J.D.H., Neal C.R., Petryk A., Georgieff M.K. Perinatal iron deficiency results in altered developmental expression of genes mediating energy metabolism and neuronal morphogenesis in hippocampus. Hippocampus 2007, 17:679-691.
14. Carlson E.S., Magid R., Petrk A., Georgieff M.K. Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. Brain Res 2008, 1237:75-83.
15. Clardy S.L., Wang X., Zhao W., Liu W., Chase G.A., Beard J.L., True Felt B., Connor J.R. Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J Neural Transm Suppl 2006, 71:173-196.
16. Connor J.R., Boyer P.J., Menzies S.L., Dellinger B., Allen R.P., Ondo W.G., Earley C.J. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304-309.
17. Connor J.R., Wand X.S., Allen R.P., Beard J.L., Wiesinger J.A., Felt B.T., Earley C.J. Altered dopaminergic profile in the putamen and substantia nigra in restless legs syndrome. Brain 2009, 132:2403-2412.
18. Connor J.R., Ponnuru P., Lee B.Y., Podskalny G.D., Alam S., Allen R.P., Earley C.J., Yang Q.X. Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome. Sleep Med 2011, 12:614-619.
19. Earley C.J., Barker Peter B., Horska A., Allen R.P. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 2006, 7:458-461.
20. Earley C.J., Horská A., Mohamed M.A., Barker P.B., Beard J.L., Allen R.P. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10:206-211.
21. Eckard J., Dai J., Wu J., Jian J., Yang Q., Chen H., Costa M., Frenkel K., Huang X. Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis - iron deficiency and angiogenesis. Cancer Cell Int 2010, 10:28.
22. Erikson K.M., Jones B.C., Beard J.L. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 2000, 130:2831-2837.
23. Erikson K.M., Jones B.C., Hess E.J., Zhang Q., Beard J.L. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmcol Biochem Behav 2001, 69:409-418.
24. Felt B.T., Beard J.L., Schallert T., Shao J., Aldridge J.W., Connor J.R., Georgieff M.K., Lozoff B. Persistent neurochemical and behavioral abnormalities in adulthood despite iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res 2006, 171:261-270.
25. Georgieff M.K. Long-term brain and behavioral consequences of early iron deficiency. Nutr Rev 2011, 69(Suppl. 1):S43-S48.
26. Godau J., Klose U., Di Santo A., Schweitzer K., Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord 2008, 23:1184-1187.
27. Guyon A., Skrzydelski D., Rovere C., et al. Stromal-cell-derived factor-1 alpha modulation of the excitability of rat substantia nigra dopaminergic neurons: presynaptic mechanisms. J Neurochem 2006, 96:1540-1550.
28. Guyon A., Nahon J.L. Multiple actions of the chemokine stromal cell-derived factor-1 alpha on neuronal activity. J Mol Endocrinol 2007, 38:365-376.
29. Guyon A., Skrzydelski D., Rovere C., et al. Stromal-cell derived factor 1 alpha/CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci 2008, 28:862-870.
30. Hitzemann R., Hitzemann B., Rivera S., Gatley J., Thanos P., Shou L.L., Williams R.W. Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: genetic relationships to alcohol and other drug associated phenotypes. Alcohol Clin Exp Res 2003, 27:1-11.
31. Jellen L.C., Beard J.L., Jones B.C. Systems genetics analysis of iron regulation in the brain. Biochimie 2009, 91:1255-1259.
32. Jellen L.C., Unger E.L., Lu L., Williams R.W., Rousseau S., Wang X., Earley C.J., Allen R.P., Miles M.F., Jones B.C. Systems genetic analysis of the effects of iron deficiency in mouse brain. Neurogenetics 2012, 13:147-157.
33. Jones B.C., Tarantino L.M., Rodriguez L.A., Reed C.L., McClearn G.E., Plomin R., Erwin V.G. Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. Pharmacogenetics 1999, 9:607-617.
34. Jones B.C., Reed C.L., Hitzemann R., Wiesinger J.A., McCarthy K.A., Buwen J.P., Beard J.L. Quantitative genetic analysis of ventral midbrain and liver iron in BXD recombinant inbred mice. Nutr Neurosci 2003, 6:369-377.
35. Kadri Z., Shimizu R., Ohneda O., Maouche-Chretien L., Gisselbrecht S., Yamamoto M., Romeo P.H., Leboulch P., Chretien S. Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol 2009, 9:e1000123.
36. Kihm A.J., Kong Y., Hong W., Russell J.E., Rouda S., Adachi K., Simon M.C., Blobel G.A., Weiss M.J. An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 2002, 417:758-763.
37. Li R., Luo C., Mines M., Zhang J., Guo-Huang F. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J Biol Chem 2006, 281:37616-37627.
38. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr 2011, 141:740S-746S.
39. Manconi M., Ulfberg J., Berger K., Ghorayeb I., Wesstrom J., Fulda S., Allen R.P., Pollmacher T. When gender matters: restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group. Sleep Med Rev. 1997, 16:297-307.
40. Pelz C.R., Kulesz-Martin M., Bagby G., Sears R.C. Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray data. BMC Bioinformatics 2008, 9:520.
41. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., Lightfoot S., Menzel W., Granzow M., Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006, 7:3.
42. Skrzydelski D., Guyon A., Dauge V., et al. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem 2007, 102:1175-1183.
43. Singh N., Haldar S., Tripathi A.K., Horback K., Wong J., Sharma D., Beserra A., et al. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal 2013, [Epub ahead of print].
44. Snyder A.M., Connor J.R. Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 2009, 1790:606-614.
45. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-15550.
46. Todorich B., Pasquini J.M., Garcia C.J., Paez P.M., Connor J.R. Oligodendrocytes and myelination: the role of iron. Glia 2009, 57:467-478.
47. Trecki J., Unterwald E.M. Modulation of cocaine-induced activity by intracerebral administration of Cxcl12. Neuroscience 2009, 161:13-22.
48. Unger E.L., Paul T., Murray-Kolb L.E., Felt B., Jones B.C., Beard J.L. Early iron deficiency alters sensorimotor development and brain monoamines in rats. J Nutr 2007, 137:118-124.
49. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochemistry 2011, 434:365-381.
50. Yin L., Unger E.L., Jellen L.C., Earley C.J., Allen R.P., Tomaszewicz A., Fleet J.C., Jones B.C. Systems genetic analysis of multivariate response to iron deficiency in mice. Am J Physiol Regul Integr Comp Physiol 2012, 302:R1282-R1296.